Top 40 Nouscom investors
The most complete profiles first. Showing 40 of 40.
Andy SchwabVerified
Venture Capital, Founder, Private Equity Firm · United States
SeedHealth CareGeneticsLife ScienceSoftwarePortfolio: Precision NanoSystem, Vor Biopharma, Aprea, Arvinas and 57 more
Verified email available
Brian AtwoodVerified
Venture Capital, Investor · United States
SeedHealth CareGeneticsCybersecurityWomen FoundedPortfolio: Black Diamond Therapeutics, Kyras Therapeutics, CRISPR Therapeutics, Aligos Therapeutics and 63 more
Verified email available
Brian DanielsVerified
Venture Capital, Private Equity Firm, Investor · United States
SeedHealth CareGeneticsLife ScienceSoftwarePortfolio: Precision NanoSystem, Vor Biopharma, Aprea, Arvinas and 52 more
Verified email available
Deborah PalestrantVerified
Venture Capital, Private Equity Firm, Investor · United States
SeedHealth CareGeneticsLife ScienceSoftwarePortfolio: Precision NanoSystem, Vor Biopharma, Aprea, Arvinas and 52 more
Verified email available
Jason RuthVerified
Venture Capital, Investor · United States
SeedHealth CareGeneticsLife ScienceSoftwarePortfolio: Precision NanoSystem, Vor Biopharma, Aprea, Arvinas and 52 more
Verified email available
Ken HaasVerified
Venture Capital, Advisor, Investor · United States
Series BHealth CareWomen FoundedLife ScienceBiotechnologyPortfolio: Kesios Therapeutics, Spruce Biosciences, Amarin, Syntaxin and 64 more
Verified email available
Lou TartagliaVerified
Venture Capital, Founder, Investor · United States
SeedHealth CareGeneticsLife ScienceSoftwarePortfolio: Precision NanoSystem, Vor Biopharma, Aprea, Arvinas and 53 more
Verified email available
Rebecca ChenVerified
Venture Capital, Private Equity Firm, Investor · United States
SeedHealth CareGeneticsLife ScienceSoftwarePortfolio: Precision NanoSystem, Vor Biopharma, Aprea, Arvinas and 52 more
Verified email available
andrew sinclairVerified
Venture Capital, Private Equity Firm, Investor · United Kingdom
Series BHealth CareWomen FoundedLife ScienceBiotechnologyPortfolio: Kesios Therapeutics, Spruce Biosciences, Amarin, Syntaxin and 64 more
Verified email available
Alexander MaywegVerified
Venture Capital, Private Equity Firm · Switzerland
Health CareGeneticsWomen FoundedLife SciencePortfolio: Black Diamond Therapeutics, Kyras Therapeutics, CRISPR Therapeutics, Aligos Therapeutics and 58 more
Verified email available
Elliot EhrichVerified
Venture Capital · United States
Health CareGeneticsLife ScienceSoftwarePortfolio: Precision NanoSystem, Vor Biopharma, Aprea, Arvinas and 52 more
Contact details available
Jonathan WeissmanVerified
Venture Capital · United States
Health CareGeneticsLife ScienceSoftwarePortfolio: Precision NanoSystem, Vor Biopharma, Aprea, Arvinas and 52 more
Contact details available
Paul StoneVerified
Venture Capital · United States
Health CareGeneticsLife ScienceSoftwarePortfolio: Precision NanoSystem, Vor Biopharma, Aprea, Arvinas and 52 more
Verified email available
Shelley ChuVerified
Venture Capital · United States
Health CareWomen FoundedLife ScienceBiotechnologyPortfolio: Kesios Therapeutics, Spruce Biosciences, Amarin, Syntaxin and 64 more
Verified email available
Tim HainesVerified
Venture Capital · United Kingdom
Health CareWomen FoundedLife ScienceBiotechnologyPortfolio: Kesios Therapeutics, Spruce Biosciences, Amarin, Syntaxin and 64 more
Verified email available
Bali Muralidhar
Venture Capital, Private Equity Firm, Investor · United Kingdom
Series BHealth CareWomen FoundedLife ScienceBiotechnologyPortfolio: Kesios Therapeutics, Spruce Biosciences, Amarin, Syntaxin and 69 more
Contact details available
Brian Gallagher, Jr.
Venture Capital, Investor · United States
Series BHealth CareWomen FoundedLife ScienceBiotechnologyPortfolio: Kesios Therapeutics, Spruce Biosciences, Aileron Therapeutics, Amarin and 67 more
Contact details available
Carlo Rizzuto
Venture Capital, Investor · United States
SeedHealth CareGeneticsWomen FoundedLife SciencePortfolio: Black Diamond Therapeutics, Kyras Therapeutics, CRISPR Therapeutics, Aligos Therapeutics and 60 more
Contact details available
Charles Warden
Venture Capital, Investor · United States
SeedHealth CareGeneticsWomen FoundedLife SciencePortfolio: Black Diamond Therapeutics, Kyras Therapeutics, CRISPR Therapeutics, Aligos Therapeutics and 61 more
Contact details available
Drew Burdon
Venture Capital, Private Equity Firm, Investor · United Kingdom
Series BHealth CareLife ScienceMobileManufacturingPortfolio: FoRx Therapeutics, Cybin, Cardiac Dimensions, AM Pharma and 63 more
Contact details available
Jamil M. Beg
Venture Capital, Investor · United States
SeedHealth CareGeneticsLife ScienceSoftwarePortfolio: Precision NanoSystem, Vor Biopharma, Aprea, Arvinas and 52 more
Contact details available
John Diekman
Venture Capital, Founder, Private Equity Firm · United States
SeedHealth CareGeneticsLife ScienceSoftwarePortfolio: Precision NanoSystem, Vor Biopharma, Aprea, Arvinas and 53 more
Contact details available
Kurt von Emster
Venture Capital, Private Equity Firm, Investor · United States
Series BHealth CareWomen FoundedInvestment ManagementLife SciencePortfolio: Kesios Therapeutics, Spruce Biosciences, Amarin, Syntaxin and 64 more
Contact details available
Martijn Kleijwegt
Venture Capital, Private Equity Firm, Investor · Netherlands
Series BHealth CareLife ScienceMobileManufacturingPortfolio: FoRx Therapeutics, Cybin, Cardiac Dimensions, AM Pharma and 63 more
Contact details available
Mason Freeman
Venture Capital, Investor · United States
SeedHealth CareHospitalsGeneticsLife SciencePortfolio: Precision NanoSystem, Vor Biopharma, Aprea, Arvinas and 52 more
Contact details available
Mira Chaurushiya
Venture Capital, Private Equity Firm, Investor · United States
SeedHealth CareGeneticsAlternative MedicineAndroidPortfolio: Precision NanoSystem, Vor Biopharma, Aprea, Arvinas and 52 more
Contact details available
Ross Jaffe
Venture Capital, Investor · United States
Series BHealth CareGeneticsWomen FoundedLife SciencePortfolio: Black Diamond Therapeutics, Kyras Therapeutics, CRISPR Therapeutics, Aligos Therapeutics and 59 more
Contact details available
Rudy Dekeyser
Venture Capital, Private Equity Firm, Investor · Belgium
Series BHealth CareHospitalsLife ScienceMobilePortfolio: FoRx Therapeutics, Cybin, Cardiac Dimensions, AM Pharma and 63 more
Contact details available
Scott Rocklage
Venture Capital, Founder, Private Equity Firm · United States
SeedHealth CareGeneticsLife ScienceSoftwarePortfolio: Precision NanoSystem, Vor Biopharma, Aprea, Arvinas and 53 more
Contact details available
Vin Miles
Venture Capital, Investor · United States
Series BHealth CareWomen FoundedLife ScienceBiotechnologyPortfolio: Kesios Therapeutics, Spruce Biosciences, Amarin, Syntaxin and 64 more
Contact details available
Vincent Brichard
Private Equity Firm, Investor · Netherlands
SeedHealth CareLife ScienceMobileManufacturingPortfolio: FoRx Therapeutics, Cybin, Cardiac Dimensions, AM Pharma and 63 more
Contact details available
Beckie Robertson
Venture Capital, Private Equity Firm · United States
Health CareGeneticsWomen FoundedLife SciencePortfolio: Black Diamond Therapeutics, Kyras Therapeutics, CRISPR Therapeutics, Aligos Therapeutics and 58 more
Contact details available
Bill Link
Venture Capital, Private Equity Firm · United States
Health CareGeneticsWomen FoundedLife SciencePortfolio: Black Diamond Therapeutics, Kyras Therapeutics, CRISPR Therapeutics, Aligos Therapeutics and 58 more
Contact details available
Don Milder
Venture Capital, Private Equity Firm · United States
Health CareGeneticsWomen FoundedLife SciencePortfolio: Black Diamond Therapeutics, Kyras Therapeutics, CRISPR Therapeutics, Aligos Therapeutics and 58 more
Contact details available
John Heard
Venture Capital, Private Equity Firm · United Kingdom
Health CareWomen FoundedLife ScienceBiotechnologyPortfolio: Kesios Therapeutics, Spruce Biosciences, Amarin, Syntaxin and 64 more
Contact details available
Joseph Victor
Venture Capital · United States
Health CareGeneticsLife ScienceSoftwarePortfolio: Precision NanoSystem, Vor Biopharma, Aprea, Arvinas and 52 more
Contact details available
Merijn Klaassen
Private Equity Firm · Netherlands
Health CareLife ScienceMobileManufacturingPortfolio: FoRx Therapeutics, Cybin, Cardiac Dimensions, AM Pharma and 63 more
Contact details available
Paul Grayson
Venture Capital · United States
Health CareGeneticsWomen FoundedLife SciencePortfolio: Black Diamond Therapeutics, Kyras Therapeutics, CRISPR Therapeutics, Aligos Therapeutics and 58 more
Contact details available
Peter Kim
Venture Capital · United States
Health CareGeneticsLife ScienceSoftwarePortfolio: Precision NanoSystem, Vor Biopharma, Aprea, Arvinas and 52 more
Contact details available
Sarah Shackelton
Venture Capital · United Kingdom
Health CareWomen FoundedLife ScienceBiotechnologyPortfolio: Kesios Therapeutics, Spruce Biosciences, Amarin, Syntaxin and 64 more
Contact details available
By investment stage
By location
Related industries
Most-backed portfolio companies
Frequently asked questions
How many Nouscom investors are on Angel Roster?
Angel Roster lists 40 Nouscom investors. 13 of them (33%) include a verified email address.
What types of investors are they?
The most common investor types are Venture Capital Firms (38), Private Equity Firms (20) and Founder-Investors (4). An investor can have more than one type, for example an angel who is also a venture partner.
Which stages do Nouscom investors invest in?
Among those that list a stage, the most common are Seed (15) and Series B (10).
Where are Nouscom investors based?
Most are based in the United States (29), the United Kingdom (6) and the Netherlands (3).
Which companies have Nouscom investors backed?
The most-backed portfolio companies among them are Audentes Therapeutics (25), Kinestral Technologies (25), Ceterix Orthopaedics (25), Aprea (25) and Crinetics Pharmaceuticals (25).
How do I contact Nouscom investors?
Create a free Angel Roster account to search and filter all 40, then unlock verified emails and LinkedIn profiles on a paid plan. Every plan starts with a 3-day free trial.